Archive for the ‘ExL Events News’ Category
Our friends over at Applied Clinical Trials Online recently shared updates gleaned from attending ExL Events’ January 2018 CROWN Congress with their audience. This article exemplifies the benefits of attending an ExL conference and we thank the publication for sharing this information.
Applied Clinical Trials shared highlights from the Congress, including the following sessions:
CRO MARKET CONSOLIDATION
Evaluating the CRO Industry Consolidation and Predictions for What’s Next
David H. Windley, CFA, CPA, Managing Director, Healthcare Equity Research, JEFFERIES LLC
PATIENT-CENTERED DIGITAL RECRUITMENT
Creating a Digital Patient Recruitment Ecosystem Focused on Patients to Optimize Engagement
Below, you’ll find an excerpt from a recent article featured in the February issue of PM360, praising ExL’s November 2017 event, the Value-Based Strategies for Reimbursement & Formulary Success conference.
The conference focused on market access and payer policies, and speakers from a number of industry giants addressed such issues as the importance of differentiating a product’s value from its therapeutic value; decreasing overall healthcare costs; proactive strategies that expand market access; and solving for the complexities HCPs face that delay patient therapy—especially in the oncology health model. Both public and private…
You might not have an inspection in two weeks, but if you did, are you prepared? ExL Events’ 4th Clinical Trial Inspection Readiness Summit is in three months, and our expert speaking faculty will help ensure you and your teams are prepared for your next inspection.
At this annual event, you will explore detailed examinations of how to handle an actual inspection, discover how to integrate technology validation into inspection readiness procedures, learn to implement the requirements of ICH E6 R2 within trial management and other related systems, select a vendor that matches the sponsor’s culture, discuss case studies,…
ExL Events invites you to download the brochure for 2018 Off-Label Regulatory Compliance Congress, taking place on May 21–22 in Herndon, VA. This must-attend event will provide attendees with the guidance and information needed to develop tactics that ensure promotional practices remain compliant with the changing regulatory landscape while advancing public health.
Determine How to Reduce Risks Involved in Off-Label Promotion
Richard Liner, Senior Compliance Counsel, BAYER HEALTHCARE
Developing Compliant Strategies in Disseminating Scientific Information to Healthcare Providers: Addressing Risk in a CIA-Focused Environment
Howard Dorfman, Distinguished Visiting Practitioner and Adjunct Professor, SETON HALL…
There’s still time to reserve your seat and get the best pricing for the 7th Drug Formulation, Solubility & Bioavailability Summit (March 26–28, Boston). We want to ensure that you have the BEST rate possible — but hurry, this exclusive rate will expire Friday, February 9!
Don’t miss our full-day seminar on advances in drug delivery; a special analysis on the use of 3D printing for new formulations; and methods for accelerating the preclinical-to-clinical data transition. All this and more from our 20+ industry leaders!
Rakesh Dixit, Vice President, R&D, Global Head,…
Before she takes the podium at our upcoming Cannabis Partnerships Congress, I had the opportunity to sit down with Focus’ Lezli Engelking to discuss cannabis regulations within the federal government and some of the challenges they face in the industry and strategies for overcoming them. The following are excerpts from that Q&A session: